Rare severe eye disorder linked to Ozempic and similar drugs, Australian watchdog warns
Australia's Therapeutic Goods Administration has issued a warning about a rare but serious eye condition, non-arteritic anterior ischemic optic neuropathy, associated with GLP-1 drugs like Ozempic. The regulator advises patients to seek medical attention if they experience sudden vision changes. This alert matters for millions of users of these popular weight-loss and diabetes medications.